Pharmaceutical Security Production Act
- Last Action
- 7/7/2023
Actions
- 2023-07-07Referred to the Subcommittee on Health.
- 2023-06-30Referred to the House Committee on Energy and Commerce.
- 2023-06-30Introduced in House
- 2023-06-30Introduced in House
CRS Summary
As of 2023-06-30 (00)
Pharmaceutical Security Production Act
This bill establishes the Commission on Strengthening the Domestic Pharmaceutical Supply Chain.
The commission must assess the security and vulnerabilities of the domestic pharmaceutical supply chain in the United States and recommend improvements, including by developing metrics for domestic manufacturing programs, proposing solutions to strengthen the domestic manufacturing workforce, and evaluating ways to support a financial market for domestically manufactured products.
The commission terminates four years after the bill is enacted.
Cosponsors (2)
- Marcus Molinaro (R-NY)
- Brian Fitzpatrick (R-PA)
Subjects
- Advisory bodies
- Congressional oversight
- Manufacturing
- Medical research
- Prescription drugs
- Research and development
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.